[Scoping review of acupuncture-moxibustion treatment for non-specific low back pain].

Researchers conducted a comprehensive review of 50 studies examining acupuncture and moxibustion treatments for non-specific low back pain—the kind of back pain without a clear structural cause like a herniated disk or fracture. They analyzed studies published through July 2023, including research from both Chinese and English medical databases. The review found that 82% of studies concluded acupuncture-moxibustion was effective for treating non-specific low back pain. Most research focused on chronic cases (lasting more than three months), which represented 68% of the studies reviewed. Treatment durations were relatively short, with 80% of studies using treatment periods under one month. However, the researchers identified several limitations in current evidence. Only 20% of studies reported information about adverse events or side effects, making it difficult to fully assess safety. Additionally, most studies had small sample sizes (50-100 participants) and short follow-up periods, with only 28% tracking patients for three months after treatment. The review also found that many studies had uncertain methodology quality, which affects how confidently we can interpret their results. While the findings suggest acupuncture-moxibustion shows promise for non-specific low back pain, the researchers emphasize that future studies need better design, longer follow-up periods, more attention to safety reporting, and consideration of psychological factors. If you're considering acupuncture for low back pain, consult with a licensed acupuncturist who can evaluate your individual condition and treatment needs.

This scoping review analyzed 50 RCTs (23 Chinese, 27 English) investigating acupuncture-moxibustion for non-specific low back pain through July 2023. Chronic NSLBP represented 68% of included studies. Sample sizes predominantly ranged from 50-100 participants, with 80% using treatment durations under one month. Fifteen intervention types were identified, with traditional acupuncture most frequently studied. The review found 82% of studies reported positive outcomes favoring acupuncture-moxibustion over controls. However, methodological concerns were evident: only 8% employed MCID thresholds, 28% included follow-up periods (maximum 3 months), and 20% reported adverse events. Risk of bias assessment showed predominantly low or uncertain risk, with limited high-risk studies excluded. Critical gaps include insufficient psychological outcome measurement, inadequate safety reporting, and unclear bias risk in many studies. Future research should prioritize larger sample sizes, extended follow-up periods, standardized outcome measures including MCID, comprehensive adverse event documentation, and rigorous methodological design to strengthen clinical applicability and evidence quality.